The forecasted hospital discharges for malignant neoplasm of the prostate in Spain indicate an upward trend from 2024 to 2028. In 2023, the value stood at 92.5 discharges per hundred thousand persons. The year-on-year variations show an increase of approximately 1.8% to 2.5% annually, with the last two years before 2024 showing an increment of about 1.7% and 1.5%. Over the next five years, the cumulative average growth rate (CAGR) is projected to be around 1.9% per year.
Future trends to watch for include advancements in medical technology, early detection and treatment options, changes in healthcare policies, and demographic shifts such as an aging population, which could further influence the discharge rates for prostate cancer. Monitoring these factors will be crucial for healthcare planning and resource allocation.
